Rifampycine induced trombositopenia: A case report

Basit Öğe Kaydı
dc.contributor.authorTanrikulu A.C.
dc.contributor.authorAbakay A.
dc.contributor.authorTuran H.
dc.date.accessioned2024-04-24T17:58:22Z
dc.date.available2024-04-24T17:58:22Z
dc.date.issued2010
dc.departmentDicle Üniversitesien_US
dc.description.abstractTuberculosis (TB) is still remained serious public health problem. Anti-TB treatment is given twice weekly caused by immun thrombocytopenia. This complication is rare when the medication is given in small daily doses (10 mg/kg). 16 years old man case with anti-TB is given daily doses (10 mg/kg) but to develop this complication is reported. This patient had applied to emergency service with epistaksis and is administered symptomatic therapy. Patients who had taken anti-TB treatment this complication to retain and should be follow.en_US
dc.identifier.doi10.5222/J.GOZTEPETRH.2010.142
dc.identifier.endpage144en_US
dc.identifier.issn1300-526X
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-77957567710en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage142en_US
dc.identifier.urihttps://doi.org/10.5222/J.GOZTEPETRH.2010.142
dc.identifier.urihttps://hdl.handle.net/11468/23874
dc.identifier.volume25en_US
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.relation.ispartofGoztepe Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRifampicinen_US
dc.subjectThrombocytopeniaen_US
dc.subjectTuberculosisen_US
dc.titleRifampycine induced trombositopenia: A case reporten_US
dc.title.alternativeRifampisine ba?li trombositopenien_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu